15,300 Shares in Avanos Medical, Inc. (NYSE:AVNS) Bought by Versor Investments LP

Versor Investments LP purchased a new stake in Avanos Medical, Inc. (NYSE:AVNS) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 15,300 shares of the company’s stock, valued at approximately $368,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Tidal Investments LLC acquired a new position in shares of Avanos Medical during the 1st quarter worth $439,000. BNP Paribas Financial Markets lifted its holdings in shares of Avanos Medical by 314.4% in the first quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock worth $1,067,000 after acquiring an additional 40,653 shares during the last quarter. Boston Partners acquired a new stake in shares of Avanos Medical in the 1st quarter valued at approximately $571,000. Quest Partners LLC bought a new stake in shares of Avanos Medical during the 2nd quarter valued at approximately $444,000. Finally, Deerfield Management Company L.P. Series C acquired a new position in Avanos Medical during the 2nd quarter worth approximately $551,000. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Price Performance

Shares of AVNS opened at $18.69 on Friday. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The stock has a market cap of $858.99 million, a PE ratio of 54.97 and a beta of 0.92. Avanos Medical, Inc. has a 12-month low of $17.39 and a 12-month high of $25.36. The business has a 50-day simple moving average of $22.30 and a two-hundred day simple moving average of $21.57.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.